Marshall Wace’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $484K | Sell |
85,124
-247,276
| -74% | -$1.4M | ﹤0.01% | 2027 |
|
2025
Q1 | $1.58M | Buy |
332,400
+281,072
| +548% | +$1.34M | ﹤0.01% | 1475 |
|
2024
Q4 | $286K | Sell |
51,328
-32,846
| -39% | -$183K | ﹤0.01% | 2096 |
|
2024
Q3 | $532K | Buy |
+84,174
| New | +$532K | ﹤0.01% | 1759 |
|
2024
Q2 | – | Sell |
-128,903
| Closed | -$935K | – | 2250 |
|
2024
Q1 | $935K | Buy |
128,903
+81,047
| +169% | +$588K | ﹤0.01% | 1471 |
|
2023
Q4 | $240K | Buy |
+47,856
| New | +$240K | ﹤0.01% | 1625 |
|
2019
Q3 | – | Sell |
-530
| Closed | -$63K | – | 1594 |
|
2019
Q2 | $63K | Buy |
530
+167
| +46% | +$19.9K | ﹤0.01% | 1250 |
|
2019
Q1 | $67K | Sell |
363
-4,155
| -92% | -$767K | ﹤0.01% | 1483 |
|
2018
Q4 | $806K | Sell |
4,518
-7,428
| -62% | -$1.33M | 0.01% | 965 |
|
2018
Q3 | $3.82M | Buy |
+11,946
| New | +$3.82M | 0.03% | 524 |
|